Status:
COMPLETED
Changes in Muscle Tissue in Patients With Pancreatic Cancer
Lead Sponsor:
Case Comprehensive Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
Brief Summary
RATIONALE: Measuring changes in muscle tissue in patients with cancer may help doctors predict how well patients will respond to treatment, and may help the study of cancer in the future. PURPOSE: Th...
Detailed Description
OBJECTIVES: * Demonstrate a decrease/increase of fat-free mass (FFM) by 10% from baseline, based on tumor progression/regression, within each patient with inoperable locally advanced or metastatic pa...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Biopsy-proven inoperable locally advanced or metastatic pancreatic adenocarcinoma
- PATIENT CHARACTERISTICS:
- ECOG performance status 0-3
- Must be able to stand unassisted on a scale
- Must not have pacemaker or implanted defibrillator
- PRIOR CONCURRENT THERAPY:
- Prior chemotherapy or radiotherapy allowed
- No concurrent use of any of the following:
- Corticosteroids
- Steroids as anti-emetics associated with chemotherapy allowed
- Anabolic steroids
- Thalidomide
- Megesterol
- Eicosapentaenoic acid (EPA)
- Nutritional supplements without EPA allowed
- Juven
- Concurrent enrollment in other clinical trials allowed
Exclusion
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00369460
Start Date
January 1 2006
End Date
July 1 2009
Last Update
October 12 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
Cleveland, Ohio, United States, 44106-5065